373 related articles for article (PubMed ID: 9032078)
1. Structure of a human lysosomal sulfatase.
Bond CS; Clements PR; Ashby SJ; Collyer CA; Harrop SJ; Hopwood JJ; Guss JM
Structure; 1997 Feb; 5(2):277-89. PubMed ID: 9032078
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis.
Lukatela G; Krauss N; Theis K; Selmer T; Gieselmann V; von Figura K; Saenger W
Biochemistry; 1998 Mar; 37(11):3654-64. PubMed ID: 9521684
[TBL] [Abstract][Full Text] [Related]
3. Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): a Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine 4-sulfatase at multiple points in the vacuolar network.
Bradford TM; Litjens T; Parkinson EJ; Hopwood JJ; Brooks DA
Biochemistry; 2002 Apr; 41(15):4962-71. PubMed ID: 11939792
[TBL] [Abstract][Full Text] [Related]
4. Human sulfatases: a structural perspective to catalysis.
Ghosh D
Cell Mol Life Sci; 2007 Aug; 64(15):2013-22. PubMed ID: 17558559
[TBL] [Abstract][Full Text] [Related]
5. Sulfatases, trapping of the sulfated enzyme intermediate by substituting the active site formylglycine.
Recksiek M; Selmer T; Dierks T; Schmidt B; von Figura K
J Biol Chem; 1998 Mar; 273(11):6096-103. PubMed ID: 9497327
[TBL] [Abstract][Full Text] [Related]
6. Feline mucopolysaccharidosis type VI. Characterization of recombinant N-acetylgalactosamine 4-sulfatase and identification of a mutation causing the disease.
Yogalingam G; Litjens T; Bielicki J; Crawley AC; Muller V; Anson DS; Hopwood JJ
J Biol Chem; 1996 Nov; 271(44):27259-65. PubMed ID: 8910299
[TBL] [Abstract][Full Text] [Related]
7. N-acetylgalactosamine-4-sulfatase: identification of four new mutations within the conserved sulfatase region causing mucopolysaccharidosis type VI.
Simonaro CM; Schuchman EH
Biochim Biophys Acta; 1995 Dec; 1272(3):129-32. PubMed ID: 8541342
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional structures of sulfatases.
Ghosh D
Methods Enzymol; 2005; 400():273-93. PubMed ID: 16399355
[TBL] [Abstract][Full Text] [Related]
9. Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients.
Litjens T; Brooks DA; Peters C; Gibson GJ; Hopwood JJ
Am J Hum Genet; 1996 Jun; 58(6):1127-34. PubMed ID: 8651289
[TBL] [Abstract][Full Text] [Related]
10. A novel protein modification generating an aldehyde group in sulfatases: its role in catalysis and disease.
von Figura K; Schmidt B; Selmer T; Dierks T
Bioessays; 1998 Jun; 20(6):505-10. PubMed ID: 9699462
[TBL] [Abstract][Full Text] [Related]
11. An N-acetylgalactosamine-4-sulfatase mutation (delta G238) results in a severe Maroteaux-Lamy phenotype.
Litjens T; Morris CP; Robertson EF; Peters C; von Figura K; Hopwood JJ
Hum Mutat; 1992; 1(5):397-402. PubMed ID: 1301949
[TBL] [Abstract][Full Text] [Related]
12. Function and structure of a prokaryotic formylglycine-generating enzyme.
Carlson BL; Ballister ER; Skordalakes E; King DS; Breidenbach MA; Gilmore SA; Berger JM; Bertozzi CR
J Biol Chem; 2008 Jul; 283(29):20117-25. PubMed ID: 18390551
[TBL] [Abstract][Full Text] [Related]
13. Two site-directed mutations abrogate enzyme activity but have different effects on the conformation and cellular content of the N-acetylgalactosamine 4-sulphatase protein.
Brooks DA; Robertson DA; Bindloss C; Litjens T; Anson DS; Peters C; Morris CP; Hopwood JJ
Biochem J; 1995 Apr; 307 ( Pt 2)(Pt 2):457-63. PubMed ID: 7733883
[TBL] [Abstract][Full Text] [Related]
14. Heparin/heparan sulfate 6-O-sulfatase from Flavobacterium heparinum: integrated structural and biochemical investigation of enzyme active site and substrate specificity.
Myette JR; Soundararajan V; Shriver Z; Raman R; Sasisekharan R
J Biol Chem; 2009 Dec; 284(50):35177-88. PubMed ID: 19726671
[TBL] [Abstract][Full Text] [Related]
15. 1.3 A structure of arylsulfatase from Pseudomonas aeruginosa establishes the catalytic mechanism of sulfate ester cleavage in the sulfatase family.
Boltes I; Czapinska H; Kahnert A; von Bülow R; Dierks T; Schmidt B; von Figura K; Kertesz MA; Usón I
Structure; 2001 Jun; 9(6):483-91. PubMed ID: 11435113
[TBL] [Abstract][Full Text] [Related]
16. Anaerobic sulfatase maturase AslB from Escherichia coli activates human recombinant iduronate-2-sulfate sulfatase (IDS) and N-acetylgalactosamine-6-sulfate sulfatase (GALNS).
Alméciga-Díaz CJ; Tolosa-Díaz AD; Pimentel LN; Bonilla YA; Rodríguez-López A; Espejo-Mojica AJ; Patiño JD; Sánchez OF; Gonzalez-Santos J
Gene; 2017 Nov; 634():53-61. PubMed ID: 28882567
[TBL] [Abstract][Full Text] [Related]
17. The human SUMF1 gene, required for posttranslational sulfatase modification, defines a new gene family which is conserved from pro- to eukaryotes.
Landgrebe J; Dierks T; Schmidt B; von Figura K
Gene; 2003 Oct; 316():47-56. PubMed ID: 14563551
[TBL] [Abstract][Full Text] [Related]
18. Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship.
Sardiello M; Annunziata I; Roma G; Ballabio A
Hum Mol Genet; 2005 Nov; 14(21):3203-17. PubMed ID: 16174644
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of human pFGE, the paralog of the Calpha-formylglycine-generating enzyme.
Dickmanns A; Schmidt B; Rudolph MG; Mariappan M; Dierks T; von Figura K; Ficner R
J Biol Chem; 2005 Apr; 280(15):15180-7. PubMed ID: 15687489
[TBL] [Abstract][Full Text] [Related]
20. Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes.
Isbrandt D; Arlt G; Brooks DA; Hopwood JJ; von Figura K; Peters C
Am J Hum Genet; 1994 Mar; 54(3):454-63. PubMed ID: 8116615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]